People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eargo, Inc. | — | Other Health Care | Series C | $187.4M | $1.8B | 2018 |
| SpyGlassPharma, Inc. | — | Other Health Care | Series C | $134.8M | $484.8M | 2020 |
| X9, Inc. | — | Other | Series A | $13.7M | $25.6M | 2022 |
Tak Cheung at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tak Cheung on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Geoff Pardo | 2 | 6 |
| Ali Behbahani | 1 | 17 |
| Kirk Nielsen | 1 | 13 |
| Joshua Makower | 1 | 10 |
| Juliet Bakker | 1 | 9 |
| Peter Bisgaard | 1 | 9 |
| David Wu | 1 | 7 |
| Zach Scheiner | 1 | 6 |
| Bilal Khan | 1 | 5 |
| David Amerson | 1 | 5 |
| PATRICK MOONEY | 1 | 4 |
| Josh Makower | 1 | 3 |
| Earl Bright | 1 | 2 |
| Christian Gormsen | 1 | 2 |
| Cynthia Yee | 1 | 2 |
| John Chang | 1 | 2 |
| Malik Kahook | 1 | 2 |
| Raphael Michel | 1 | 2 |
| David Tuxen Wu | 1 | 1 |
| Raphael Tuxen Michel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.